Observational analysis of mesh related complications in urogynecologic procedures
- 24 Downloads
Since the 1990s, the use of mesh has expanded in gynecologic surgeries in the aim of correcting pelvic organ prolapse. Because there has been a lot of complications that were reported, the U.S. Food and Drug Administration has requested the withdrawal of many products from the market. Recently, many countries have called for the suspension of vaginal mesh products from the market. The objective of this review is to analyze the incidence of the complications that arise after vaginal mesh surgeries with an insight to the American College of Obstetricians and Gynecologists recommendations on the management of those complications.
KeywordsPelvic organ prolapse Mesh use Graft complications
Compliance with ethical standards
Conflict of interest
Bassel Abouzeid, MD declares that he has no conflict of interest. Georges El Hasbani, MD declares that he has no conflict of interest. Imad Mufarrij, MD, MS, FACOG declares that he has no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Davidson ER, Casas-Puig V, Paraiso MF, Ridgeway B, Ferrando C (2019) Pelvic organ prolapse recurrence and patient-centered outcomes following minimally invasive abdominal uterosacral ligament and mesh-augmented sacrohysteropexy. Female Pelvic Med Reconstr Surg. https://doi.org/10.1097/spv.0000000000000710 (publish ahead of print) Google Scholar
- 6.Fatton B, Amblard J, Debodinance P, Cosson M, Jacquetin B (2007) Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift technique)—a case series multicentric study. Int Urogynecol J Pelvic Floor Dysfunct 18(7):743–752. https://doi.org/10.1007/s00192-006-0234-3 CrossRefGoogle Scholar
- 7.Murphy M, Holzberg A, van Raalte H et al (2012) Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: “UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse”. Int Urogynecol J 23(1):5–9. https://doi.org/10.1007/s00192-011-1581-2 CrossRefGoogle Scholar
- 13.Gynecological mesh: The medical device that has 100,000 women suing. https://www.cbsnews.com/news/boston-scientific-gynecological-mesh-the-medical-device-that-has-100000-women-suing-2019-04-17/. Accessed 19 May 2019
- 14.Kaplan S, Goldstein M (2019) F.D.A. Halts U.S. sales of pelvic mesh, citing safety concerns for women. The New York Times. https://www.nytimes.com/2019/04/16/health/vaginal-pelvic-mesh-fda.html. Accessed 19 May 2019
- 15.(2017) Management of mesh and graft complications in gynecologic surgery. Female Pelvic Med Reconstr Surg 23(3):171–176. https://doi.org/10.1097/spv.0000000000000425
- 17.Melody GF (1955) PARAVAGINAL HEMATOMAS—their recognition and management postpartum. Calif Med 82(1):16–18Google Scholar
- 19.Lagerbäck T, Fritzell P, Hägg O et al (2018) Effectiveness of surgery for sciatica with disc herniation is not substantially affected by differences in surgical incidences among three countries: results from the Danish, Swedish and Norwegian spine registries. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. https://doi.org/10.1007/s00586-018-5768-9 Google Scholar
- 23.(2007) Stedman’s Medical Dictionary, 28th ed. Ref Rev 21(1):41–42. https://doi.org/10.1108/09504120710719671